MediPharm Labs Corp. (LABS.TO)
Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
At close: 02:43PM EDT
| Previous close | 0.0750 |
| Open | 0.0750 |
| Bid | 0.0750 x N/A |
| Ask | 0.0800 x N/A |
| Day's range | 0.0750 - 0.0800 |
| 52-week range | 0.0550 - 0.1000 |
| Volume | |
| Avg. volume | 266,938 |
| Market cap | 32.385M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings date | 14 Aug 2024 - 24 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireMediPharm Labs Reports First Quarter Results
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024.
PR NewswireMediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the period ended March 31, 2024, before markets open on Wednesday, May 15, 2024.
Simply Wall St.MediPharm Labs Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
MediPharm Labs ( TSE:LABS ) Full Year 2023 Results Key Financial Results Revenue: CA$33.1m (up 50% from FY 2022). Net...
© 2024 Yahoo. All rights reserved.